[29-52-pm1] Clinical Pharmacy 27, Pharmacotherapies (Cancer)

[29-52-pm1-05S] The impact of proton pump inhibitors on prognosis and adverse events of osimertinib in patients with non-small cell lung cancer

○Sachiho Harada¹, Miki Sato^1,2, Ryo Manabe³, Sojiro Kusumoto³, Saeko kashimura⁴, Masayuki Ohbayashi^1,2, Noriko Kohyama^1,2, Akihiko Tanaka³, Mari Kogo^1,2 (1. Showa Med. Univ. Sch. Pharm., 2. Showa Univ. Grad. Sch. Pharm., 3. Division of Respiratory Medicine and Allergology, Showa Med. Univ. Hospital, 4. Pharm, Showa Med. Univ. Koto Toyosu Hospital)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.